249 related articles for article (PubMed ID: 26077429)
1. DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate.
Keil KP; Vezina CM
Epigenomics; 2015; 7(3):413-25. PubMed ID: 26077429
[TBL] [Abstract][Full Text] [Related]
2. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
4. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
5. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog signaling in prostate growth and benign prostate hyperplasia.
Vezina CM; Bushman AW
Curr Urol Rep; 2007 Jul; 8(4):275-80. PubMed ID: 18519011
[TBL] [Abstract][Full Text] [Related]
7. [IDENTIFICATION OF A NEW DIAGNOSTIC MARKERS OF PROSTATIC CANCER, USING NOTI-MICROCHIPS].
Vozianov SO; Kashuba VI; Grygorenko VM; Gordiyuk VV; Danylets RO; Bondarenko YM; Vikarchuk MV
Klin Khir; 2016 Apr; (4):54-7. PubMed ID: 27434957
[TBL] [Abstract][Full Text] [Related]
8. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
9. AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer.
Ponomareva L; Liu H; Duan X; Dickerson E; Shen H; Panchanathan R; Choubey D
Mol Cancer Res; 2013 Oct; 11(10):1193-202. PubMed ID: 23864729
[TBL] [Abstract][Full Text] [Related]
10. A quantitative promoter methylation profile of prostate cancer.
Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor DNA methylation regulates the timing and androgen sensitivity of mouse prostate ductal development.
Keil KP; Abler LL; Laporta J; Altmann HM; Yang B; Jarrard DF; Hernandez LL; Vezina CM
Dev Biol; 2014 Dec; 396(2):237-45. PubMed ID: 25446526
[TBL] [Abstract][Full Text] [Related]
12. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
13. Morphogenetic concepts of normal and abnormal growth in the human prostate.
Bonkhoff H; Remberger K
Virchows Arch; 1998 Sep; 433(3):195-202. PubMed ID: 9769121
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.
Peng YC; Joyner AL
Dev Biol; 2015 Apr; 400(1):94-104. PubMed ID: 25641695
[TBL] [Abstract][Full Text] [Related]
15. Fingerprinting the diseased prostate: associations between BPH and prostate cancer.
Shah US; Getzenberg RH
J Cell Biochem; 2004 Jan; 91(1):161-9. PubMed ID: 14689588
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.
Ahmed H; Banerjee PP; Vasta GR
Biochem Biophys Res Commun; 2007 Jun; 358(1):241-6. PubMed ID: 17481580
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
[TBL] [Abstract][Full Text] [Related]
18. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
Schaeffer EM; Marchionni L; Huang Z; Simons B; Blackman A; Yu W; Parmigiani G; Berman DM
Oncogene; 2008 Dec; 27(57):7180-91. PubMed ID: 18794802
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
[TBL] [Abstract][Full Text] [Related]
20. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
